Men's Health News

November 7, 2016

Low Testosterone Therapy Tied to Dementia

Metastatic Prostate Cancer Cases Skyrocket

98% Cure Rate for Prostate Cancer Using SBRT

Cancer Death Rate Continues Steady Drop

Latest Headlines

updated 4:59pm EST

Do Second Opinions Matter in Prostate Cancer Care?

Nov. 7, 2016 — Many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in treatment choice or improvements ... read more

Tumor Cells in Blood Samples Could Predict Prostate Cancer Spread

Nov. 4, 2016 — Researchers have found a group of circulating tumor cells in prostate cancer patient blood samples that are linked to the spread of the disease, according to new ... read more

Significant Decrease Seen in Prostate Biopsy, Radical Prostatectomy Procedures Following Recommendations

Nov. 2, 2016 — Researchers examined effects on practice patterns in prostate cancer diagnosis and treatment following the U.S. Preventative Services Task Force ... read more

Identification of Gene Defects Helps Treatment of Prostate Cancer

Nov. 4, 2016 — The current method of treating prostate cancer involves identifying gene defects, which could help with the diagnosis of cancer and the development of individualized cancer treatments for patients. ... read more

Risk Factors for Prostate Cancer Aren't What We Think, Study Shows

Nov. 1, 2016 — When it comes to prostate cancer biopsies, risk and reality don’t always match up, according to research. Investigators found widespread detection bias after a fresh examination of data from the ... read more

New Research Reveals Link Between Molecular Mechanisms in Prostate Cancer, Ewing's Sarcoma

Oct. 25, 2016 — Medical researchers have found evidence for a link between prostate cancer, which affects millions of men aged 50 and older, and Ewing’s sarcoma, a ... read more

More American Men With Early-Stage Prostate Cancer Could Opt out of Immediate Treatment

Oct. 20, 2016 — A new report on Swedish men with non-aggressive prostate cancer suggests that a lot more American men could safely choose to monitor their disease ... read more

African-American, Hispanic Men Less Likely to Get Treatment for Prostate Cancer, Even With High-Risk Disease

Oct. 7, 2016 — African-American and Hispanic men in the United States are less likely to receive therapy for prostate cancer compared to Caucasian men — even when ... read more

Three Novel Intrinsic Subtypes of Prostate Cancer Identified

Sep. 26, 2016 — In the largest study of its kind to date, researchers have identified and validated three distinct molecular subtypes of prostate cancer that correlate with distant metastasis-free survival and can ... read more

Use of PSA for Prostate Screening Unaffected by Changes in Screening Guidelines, Research Finds

Oct. 6, 2016 — Controversy over prostate cancer screening guidelines that discourage use of PSA tests did not significantly reduce use of the test, a five-year ... read more

Cancer 'smoke Alarm' Could Aid Early Diagnosis

Treat or Monitor Early Prostate Cancer?

Zika Vaccine Trials Begin In Baltimore

How A Florida Teen Survived A Rare Brain-Eating Amoeba Infection

Researchers Map Prostate Cancer Relapse Using C-11 Choline PET and MRI

Oct. 5, 2016 — A team of researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found ... read more

How Cancer's 'Invisibility Cloak' Works

Sep. 30, 2016 — Researchers have discovered how cancer cells become invisible to the body's immune system, a crucial step that allows tumors to metastasize and spread throughout the ... read more

Consumption of a Bioactive Compound from Neem Plant Could Significantly Suppress Development of Prostate Cancer

Sep. 29, 2016 — Oral administration of nimbolide, over 12 weeks shows reduction of prostate tumor size by up to 70 per cent and decrease in tumor metastasis by up to 50 per cent, report ... read more

Cardiac Risk a Factor When Considering Hormonal Therapy for Prostate Cancer

Sep. 28, 2016 — Men who received hormonal therapy for prostate cancer had a net harm if they had a prior history of a heart attack, new research ... read more

Shortened Radiation Therapy Offers Similar Quality of Life for Low-Risk Prostate Cancer Patients

Sep. 26, 2016 — Low-risk prostate cancer patients may be able to undergo a shortened course of radiation therapy that cuts treatment by weeks and offers comparable outcomes and quality of life results as those who ... read more

Intermediate Risk Prostate Cancer May Be Well Controlled With Brachytherapy Alone

Sep. 26, 2016 — For men with intermediate risk prostate cancer, radiation treatment with brachytherapy alone can result in similar cancer control with fewer long-term side effects, when compared to more aggressive ... read more

Hypofractionated Radiation Therapy Can Reduce Treatment Time by One-Third With Comparable QOL for Prostate Cancer Patients

Sep. 26, 2016 — For men with early stage, low-risk prostate cancer, treatment with hypofractionated radiation therapy (RT) offers comparable health-related quality of life outcomes in one-third less treatment time ... read more

Radiation Therapy, Radical Prostatectomy Further Explored for Initial Diagnosis of Advanced Prostate Cancer

Sep. 26, 2016 — A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the ... read more

SBRT Offers Prostate Cancer Patients High Cancer Control and Low Toxicity in Fewer Treatments

Sep. 26, 2016 — High dose stereotactic body radiotherapy (SBRT) for men newly-diagnosed with low- or intermediate-risk prostate cancer results in shorter treatment times, low severe toxicity and excellent cancer ... read more

Extremely Hypofractionated Radiation Therapy Shows Promising Toxicity Results for Intermediate Risk Prostate Cancer Patients

Sep. 26, 2016 — For men with intermediate risk prostate cancer, side effects at two years following radiation therapy (RT) were comparable for extremely-hypofractionated treatment, which was delivered in seven ... read more